Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Summaries for patients. The cost-effectiveness of preventive strategies for breast and ovarian cancer for women with BRCA1 or BRCA2 mutations.

Annals of internal medicine - 21 Mar 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Genes, BRCA1
Share to Genes, BRCA2
Share to Markov Chains

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastectomy

Share to Monte Carlo Method

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 16549849
DOI: 10.7326/0003-4819-144-6-200603210-00002

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Summaries for patients. The cost-effectiveness of preventive strategies for breast and ovarian cancer for women with BRCA1 or BRCA2 mutations.PMID 16549849Read ↗

Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.Semantic proximity Read ↗

Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.Semantic proximity Read ↗

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.Semantic proximity Read ↗

Summaries for patients. Validity of models for predicting BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Summaries for patients. Do women with breast cancer overestimate their risk for cancer in the unaffected breast?Semantic proximity Read ↗

Availability and payer coverage of BRCA1/2 tests and gene panels.Semantic proximity Read ↗

Estimation of Healthcare-related Charges in Women with BRCA Mutations and Breast Cancer Semantic proximity Read ↗

Summaries for patients. Cost-effectiveness of screening for microsatellite instability to detect hereditary nonpolyposis colorectal cancer.Semantic proximity Read ↗

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.Semantic proximity Read ↗

Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations.Semantic proximity Read ↗

Estimation of healthcare-related charges in women with BRCA mutations and breast cancer.Semantic proximity Read ↗

Summaries for patients. Breast cancer in men.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.